Masters Capital Management LLC Sells 298,500 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Masters Capital Management LLC trimmed its position in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 59.9% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 200,000 shares of the construction company’s stock after selling 298,500 shares during the quarter. Masters Capital Management LLC’s holdings in Aspen Aerogels were worth $3,156,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ASPN. McAdam LLC purchased a new position in shares of Aspen Aerogels in the 4th quarter worth approximately $191,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Aspen Aerogels by 38.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after acquiring an additional 3,607 shares in the last quarter. Cornerstone Investment Partners LLC bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $230,000. Raymond James Financial Services Advisors Inc. bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $265,000. Finally, WealthTrust Axiom LLC bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $296,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Price Performance

Shares of ASPN stock traded up $1.21 on Wednesday, reaching $30.44. The company’s stock had a trading volume of 1,334,714 shares, compared to its average volume of 1,135,753. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24. Aspen Aerogels, Inc. has a 12-month low of $5.32 and a 12-month high of $31.74. The company has a market capitalization of $2.32 billion, a P/E ratio of -70.70 and a beta of 2.29. The stock’s 50 day simple moving average is $22.96 and its 200-day simple moving average is $17.43.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its quarterly earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.14. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. The business had revenue of $94.50 million for the quarter, compared to the consensus estimate of $73.04 million. As a group, equities analysts predict that Aspen Aerogels, Inc. will post 0.08 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. TD Cowen increased their price objective on Aspen Aerogels from $30.00 to $36.00 and gave the company a “buy” rating in a report on Wednesday, June 5th. Piper Sandler increased their price objective on Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, May 29th. Roth Mkm reaffirmed a “buy” rating and issued a $36.00 price target (up from $28.00) on shares of Aspen Aerogels in a report on Wednesday. B. Riley raised their price target on Aspen Aerogels from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. Finally, HC Wainwright raised their price target on Aspen Aerogels from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating and seven have given a buy rating to the company’s stock. According to MarketBeat, Aspen Aerogels presently has an average rating of “Moderate Buy” and a consensus price target of $29.71.

View Our Latest Report on ASPN

Insider Buying and Selling at Aspen Aerogels

In other news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the firm’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $23.50, for a total transaction of $82,250,000.00. Following the transaction, the insider now directly owns 12,280,426 shares of the company’s stock, valued at $288,590,011. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, SVP Keith L. Schilling sold 20,000 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $26.84, for a total value of $536,800.00. Following the sale, the senior vice president now directly owns 28,792 shares of the company’s stock, valued at $772,777.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the firm’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $23.50, for a total value of $82,250,000.00. Following the completion of the sale, the insider now directly owns 12,280,426 shares in the company, valued at $288,590,011. The disclosure for this sale can be found here. Insiders have sold 3,832,103 shares of company stock worth $91,679,369 over the last 90 days. Corporate insiders own 4.30% of the company’s stock.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

See Also

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.